Learn More
Medchemexpress LLC N-(3-chlorophenyl)-8-[[1-(4-methyl-2-nitrophenyl)-1H-1,2,3-triazol-4-yl]methoxy]-2-quinazolinamine | 2587177-94-2 | 98.3% | C24H18ClN7O3 | 10MG

Supplier: Medchemexpress LLC HY13197810MG
DB18 is a small-molecule inhibitor of CDC2-like kinases (CLKs) with potent, selective activity and reported anti-tumor effects. The compound exhibits low-nanomolar inhibition of CLK isoforms and is supplied as a high-purity solid for research applications.
- Potent, selective inhibitor of CDC2-like kinases (CLKs).
- Low-nanomolar IC50 (10-30 nM) for CLK1, CLK2, and CLK4.
- Demonstrated anti-tumor activity in preclinical studies.
- High purity suitable for biochemical assays.
- Soluble in DMSO at 50 mg/mL with ultrasonic warming.
- Stable when stored under recommended conditions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.